Fermion develops, manufactures and markets active pharmaceutical ingredients (APIs) to companies in global generic market as well as under exclusive contracts to companies focusing on new chemical entities (NCEs). Our API product portfolio consists of over 30 generic APIs and over 10 NCEs. Fermion’s two state-of-the-art manufacturing sites as well as R&D facilities including a modern bench scale operation are all located in Finland. Fermion has systematically invested and expanded capabilities in the production of highly potent compounds (HPAPIs). Fermion is fully owned subsidiary of Orion Corporation.
Visit Company Website
